Clinical Trials
Rina-S Shows Promise in Advanced Ovarian Cancer
Genmab has reported encouraging findings from the Phase 2 RAINFOL-01 trial of rinatabart sesutecan (Rina-S®), an experimental folate receptor-alpha (FRα)-targeted, TOPO1 antibody-drug combination (ADC). Data from the B1 cohort of the trial showed encouraging antitumor efficacy in highly pre-treated...
News
Pharma Support Powers Sofinnova Biotech Acceleration Fund
Sofinnova Partners Closes €165M Biotech Acceleration Fund with Strong Pharma Support
European life sciences investment firm Sofinnova Partners has announced the final close of its second biotech acceleration fund, raising €165 million and surpassing its original target. The fund, Sofinnova...
News
The Best Type of Accreditation for a Telehealth Provider
Telehealth and remote patient monitoring services are becoming more prominent throughout the world. However, as more health care providers aim to deliver assistance through this medium, it is important to maintain quality, safety and effectiveness. The right accreditation or...
BioPharma
Pharmaceutical Contract Sales Market to Hit $26.24B by 2034
Contract Sales Organizations: Transforming Pharma Companies
Contract sales organizations – CSOs are becoming vital tools for pharmaceutical companies to boost sales performance while keeping marketing costs low. These organizations happen to offer experts who work alongside pharmaceutical companies in order...
News
What Are the Benefits of Outsourcing to a Clinical Research Organization?
Have you ever wondered if outsourcing certain tasks could benefit your business? Are you struggling with limited resources, tight deadlines, or regulatory complexities? For many organizations in the healthcare and pharmaceutical sectors, outsourcing has become a strategic way to...
News
What’s Missing from Drug Warning Labels? A Look at Patient Safety
Drug warning labels are meant to protect patients. But do they tell the whole story? Many labels focus on short-term risks and leave out long-term dangers. Some side effects take years to appear.
Others only come to light after thousands...
News
Indian Pharma Grows 8% CAGR, Surpassing Global Average
The Indian pharma sector has seen 8% CAGR growth and at the same time has witnessed a 9% rise when it comes to export rates in 2024, as per one of the reports. McKinsey & Company’s report has shown...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from any location or device.
Must read
